BSE · PARMAX.BO
Parmax Pharma Limited
₹135.05-₹1.35 (-0.99%)
Parmax Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
Loading market information…
BSE · BERLDRG.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Beryl Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 7.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Beryl Drugs Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Beryl Drugs Limited focuses on the manufacturing of bulk pharmaceutical ingredients. Its comprehensive product portfolio encompasses liquid and dry small-volume injectable medications, ophthalmic and otic solutions, intravenous (IV) fluids supplied in both polypack and glass bottles, and a variety of veterinary pharmaceuticals. The company was established on August 24, 1993, and maintains its corporate headquarters in Indore, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹135.05-₹1.35 (-0.99%)
Parmax Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
₹72.39+₹2.39 (+3.41%)
Colinz Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 17.65% below the high.
₹27.25₹0.00 (0.0%)
Shamrock Industrial Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
₹22.86+₹0.12 (+0.53%)
Emmessar Biotech & Nutrition Limited’s quoted price sits in the lower half of its reported 52-week range, 31.52% below the high.
₹20.39-₹0.59 (-2.81%)
Nexus Surgical and Medicare Limited’s quoted price sits in the lower half of its reported 52-week range, 43.03% below the high.
₹22.00₹0.00 (0.0%)
Dhanvantri Jeevan Rekha Limited’s quoted price sits in the lower half of its reported 52-week range, 26.67% below the high.
₹8.85-₹0.46 (-4.94%)
Trinity League India Limited’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
₹1.56+₹0.13 (+9.09%)
Vivanza Biosciences Limited’s quoted price sits in the lower half of its reported 52-week range, 42.65% below the high.
